- Home
- ABVX vs SIGI Comparison
ABVX vs SIGI Comparison
Compare ABVX & SIGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVX
- SIGI
- Stock Information
- Founded
- ABVX 2013
- SIGI 1926
- Country
- ABVX France
- SIGI United States
- Employees
- ABVX N/A
- SIGI N/A
- Industry
- ABVX
- SIGI Property-Casualty Insurers
- Sector
- ABVX
- SIGI Finance
- Exchange
- ABVX Nasdaq
- SIGI Nasdaq
- Market Cap
- ABVX 5.3B
- SIGI 5.5B
- IPO Year
- ABVX N/A
- SIGI N/A
- Fundamental
- Price
- ABVX $70.44
- SIGI $76.71
- Analyst Decision
- ABVX Buy
- SIGI Hold
- Analyst Count
- ABVX 7
- SIGI 7
- Target Price
- ABVX $74.86
- SIGI $87.33
- AVG Volume (30 Days)
- ABVX 3.2M
- SIGI 810.9K
- Earning Date
- ABVX 08-11-2025
- SIGI 07-23-2025
- Dividend Yield
- ABVX N/A
- SIGI 1.98%
- EPS Growth
- ABVX N/A
- SIGI 66.75
- EPS
- ABVX N/A
- SIGI 6.11
- Revenue
- ABVX $11,444,012.00
- SIGI $5,112,631,000.00
- Revenue This Year
- ABVX N/A
- SIGI $5.31
- Revenue Next Year
- ABVX $41.36
- SIGI $6.91
- P/E Ratio
- ABVX N/A
- SIGI $12.56
- Revenue Growth
- ABVX 128.98
- SIGI 12.30
- 52 Week Low
- ABVX $4.77
- SIGI $71.75
- 52 Week High
- ABVX $75.51
- SIGI $103.56
- Technical
- Relative Strength Index (RSI)
- ABVX 80.00
- SIGI 38.94
- Support Level
- ABVX $68.26
- SIGI $76.98
- Resistance Level
- ABVX $73.90
- SIGI $79.47
- Average True Range (ATR)
- ABVX 3.64
- SIGI 1.83
- MACD
- ABVX -1.64
- SIGI 0.03
- Stochastic Oscillator
- ABVX 46.06
- SIGI 6.99
About ABVX Abivax SA American
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.
About SIGI Selective Insurance Group Inc.
Selective Insurance Group Inc is a regional property-casualty insurer based in New Jersey, with its operations focused in the New York metropolitan area. The Company has four operating segments: Standard Commercial Lines, Standard Personal Lines, E&S Lines, Investments. Majority of revenue is gained from Standard Personal Lines. Currently company has it's revenues from States of USA and Columbia.